Weight Management

A compounded medication is prepared by a licensed pharmacy for an identified patient based on a valid prescription from a licensed healthcare provider.

Compounding may involve changing the prescribed strength, dosage form, ingredients, or method of administration to meet a documented patient-specific need that cannot appropriately be addressed by an available manufactured medication.

Compounded medications are not FDA-approved. This means the FDA does not individually review each compounded preparation for safety, effectiveness, or quality before it is dispensed.

A compounding pharmacy works with the prescribing provider to prepare a medication that follows the patient-specific prescription.

Depending on the patient’s clinical needs and applicable laws, this may involve:

• Preparing a prescribed strength that is not commercially available

• Providing an alternative dosage form

• Removing an inactive ingredient the patient cannot tolerate

• Preparing a formulation that supports more accurate administration

• Helping the provider evaluate formulation feasibility

• Educating the patient about proper use, measurement, storage, and handling

The pharmacy does not diagnose obesity or independently determine which medication a patient should receive. Those decisions remain with the licensed prescribing provider.

No. Olive Tree Compounding Pharmacy does not independently diagnose patients or prescribe prescription weight-management medications.

Patients must first be evaluated by a qualified healthcare provider. If the provider determines that medication is appropriate, the provider may send a valid prescription to the pharmacy.

Our pharmacists can then review the prescription, evaluate whether the requested formulation can be prepared legally and appropriately, and communicate with the provider when clarification is needed.

No. Prescription compounded medications require a valid prescription from a licensed healthcare provider for an identified patient.

A patient should be medically evaluated before beginning prescription weight-management treatment. The evaluation may include the patient’s health history, current medications, body-weight history, treatment goals, laboratory findings, and risk factors.

Federal law governing traditional pharmacy compounding generally requires patient-specific prescriptions.

Availability depends on the prescription, the patient’s documented clinical need, the ingredients requested, federal and state law, current FDA policy, and the pharmacy’s ability to prepare the formulation appropriately.

Compounded GLP-1 medications should not be presented as generic versions or equivalent substitutes for FDA-approved products. Compounded medications are not FDA-approved and are not reviewed by the FDA in the same way as approved branded or generic drugs.

FDA has declared the national shortages of semaglutide injection and tirzepatide injection resolved. As a result, pharmacies generally may not produce routine copies of these commercially available products simply because they are less expensive or more convenient. A prescriber must identify a legitimate patient-specific clinical difference when applicable.

Patients and providers should contact Olive Tree directly to discuss whether a specific prescription can legally and appropriately be filled.

A provider may consider compounding when an available manufactured medication cannot appropriately meet a specific patient’s medical needs.

Examples may include:

• A clinically necessary strength that is not commercially available

• An allergy or sensitivity to an inactive ingredient

• Difficulty using an available dosage form

• A patient-specific administration challenge

• A clinically significant difference identified by the prescriber

Compounding should not be used merely to make an exact copy of an available FDA-approved medication or to market a lower-cost substitute without a legitimate clinical basis.

Olive Tree Compounding Pharmacy provides patient-specific pharmacy support built around provider collaboration, responsible compounding, clear communication, and patient education.

We do not believe weight management should be built around a generic promise or a single medication. Our role is to help providers translate an appropriate clinical plan into a carefully prepared prescription when compounding is justified and legally permitted.

Patients receive guidance on proper administration, storage, and handling, while providers have access to a pharmacy team that can answer formulation questions and support continuity of care.

For Patients: Speak with your healthcare provider to determine whether prescription weight-management treatment is appropriate for you.

For Providers: Contact Olive Tree Compounding Pharmacy to discuss a documented patient-specific formulation need.

Shipping eligibility depends on the medication, prescription, patient location, applicable state law, and Olive Tree Compounding Pharmacy’s licensure in the patient’s state.

Patients and providers should contact our pharmacy to confirm whether a prescription can be dispensed or shipped to the patient’s location.

Yes. Olive Tree Compounding Pharmacy collaborates with licensed healthcare providers who need pharmacy support for appropriate patient-specific prescriptions.

Our team can assist with:

• Formulation-feasibility questions

• Available dosage forms and concentrations

• Prescription clarification

• Patient administration education

• Storage and handling guidance

• Refill coordination

• Communication about patient-specific formulation requirements

Providers should contact our pharmacy team before promising a compounded medication to a patient, particularly when the prescription involves a drug affected by current FDA shortage or compounding policies.

A compounded preparation may address a particular strength, ingredient, dosage-form, or administration need identified by the prescriber. However, customization does not guarantee that a patient will avoid side effects.

The prescriber remains responsible for selecting the medication and determining whether the potential benefits outweigh the risks. Patients should report persistent or severe side effects rather than changing the dose or schedule independently.

Patient education is especially important when a medication must be measured before administration.

FDA has reported dosing errors involving compounded injectable semaglutide, including cases in which patients administered substantially more medication than intended. Confusion may occur when instructions use different units, concentrations, vial sizes, or syringe markings.

To support safer use, pharmacists may:

• Confirm that the prescription directions are clear

• Explain the prescribed dose and measuring device

• Demonstrate how to interpret syringe markings when appropriate

• Provide written administration instructions

• Review storage and handling requirements

• Encourage patients to contact the pharmacy before administering a dose they do not understand

Patients should never estimate their dose or change it without instructions from their prescriber.